We are live on
!
Find out more
Thrivent Financial for Lutherans Portfolio holdings
AUM
$52.5B
1-Year Est. Return
27.12%
This Fund
S&P 500
This Quarter
Est. Return
-14.49%
1 Year Est. Return
+27.12%
3 Year Est. Return
+79.38%
5 Year Est. Return
+100.59%
10 Year Est. Return
+446.23%
AUM
$37.5B
AUM Growth
-$13.6B
(-27%)
Cap. Flow
-$5.63B
Cap. Flow
% of AUM
-15%
Top 10 Holdings %
Top 10 Hldgs %
13.76%
Holding
2,591
New
98
Increased
1,277
Reduced
945
Closed
185
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Labcorp
LH
|
+$217M |
| 2 |
Casey's General Stores
CASY
|
+$114M |
| 3 |
Nike
NKE
|
+$98.8M |
| 4 |
Warner Bros
WBD
|
+$98.3M |
| 5 |
HR
Healthcare Realty Trust Incorporated
HR
|
+$85.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vident US Equity Strategy ETF
VUSE
|
+$429M |
| 2 |
iShares Core S&P US Value ETF
IUSV
|
+$395M |
| 3 |
Vident International Equity Strategy
VIDI
|
+$393M |
| 4 |
Vident US Bond Strategy ETF
VBND
|
+$371M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$321M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.74% |
| 2 | Financials | 12.97% |
| 3 | Healthcare | 11.8% |
| 4 | Industrials | 10.71% |
| 5 | Consumer Discretionary | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Vanda Pharmaceuticals
VNDA
$302M
| $605K | ﹤0.01% |
55,499
+10,145
| +22% | +$105K |
|
1927
iShares 7-10 Year Treasury Bond ETF
IEF
$47.3B
| $604K | ﹤0.01% |
5,908
-392,025
| -99% | -$40.2M |
|
|
GES
1928
DELISTED
Guess Inc
GES
| $601K | ﹤0.01% |
35,232
+3,495
| +11% | +$72.7K |
|
1929
8x8 Inc
EGHT
$332M
| $599K | ﹤0.01% |
116,255
+19,925
| +21% | +$167K |
|
1930
Viasat
VSAT
$11.1B
| $598K | ﹤0.01% |
19,529
+90
| +0.5% | +$3.48K |
|
|
HNGR
1931
DELISTED
Hanger Inc.
HNGR
| $598K | ﹤0.01% |
41,731
+11,795
| +39% | +$191K |
|
1932
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.65B
| $596K | ﹤0.01% |
14,604
+5,008
| +52% | +$223K |
|
1933
AES
AES
$10.5B
| $595K | ﹤0.01% |
28,342
-13,766
| -33% | -$300K |
|
1934
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$41.7B
| $594K | ﹤0.01% |
20,613
+7,862
| +62% | +$249K |
|
1935
Manitowoc
MTW
$675M
| $593K | ﹤0.01% |
56,299
+42,878
| +319% | +$537K |
|
1936
Collegium Pharmaceutical
COLL
$956M
| $591K | ﹤0.01% |
33,377
+5,235
| +19% | +$88.1K |
|
1937
American Vanguard Corp
AVD
$68.9M
| $589K | ﹤0.01% |
26,337
+4,428
| +20% | +$99K |
|
|
BIG
1938
DELISTED
Big Lots, Inc.
BIG
| $588K | ﹤0.01% |
28,057
+3,195
| +13% | +$94K |
|
|
TBI
1939
Trueblue
TBI
$311M
| $586K | ﹤0.01% |
32,743
+3,804
| +13% | +$89.3K |
|
1940
Leidos
LDOS
$17.3B
| $584K | ﹤0.01% |
5,799
-136
| -2% | -$14.1K |
|
1941
Best Buy
BBY
$17.3B
| $583K | ﹤0.01% |
8,947
-573
| -6% | -$47.8K |
|
1942
Graham Holdings Company
GHC
$5.02B
| $583K | ﹤0.01% |
1,028
-1,014
| -50% | -$603K |
|
1943
Pitney Bowes
PBI
$2.39B
| $580K | ﹤0.01% |
160,166
+25,436
| +19% | +$116K |
|
1944
Sportsman's Warehouse
SPWH
$46M
| $574K | ﹤0.01% |
+59,849
| New | +$590K |
|
1945
Atara Biotherapeutics
ATRA
$76.1M
| $573K | ﹤0.01% |
+2,946
| New | +$481K |
|
|
AAMI
1946
Acadian Asset Management
AAMI
$3.19B
| $572K | ﹤0.01% |
31,745
+3,233
| +11% | +$66.2K |
|
1947
iShares US Pharmaceuticals ETF
IHE
$1.64B
| $571K | ﹤0.01% |
8,943
-1,857
| -17% | -$118K |
|
1948
Nu Skin
NUS
$267M
| $570K | ﹤0.01% |
13,172
+153
| +1% | +$7.02K |
|
1949
C.H. Robinson
CHRW
$17.5B
| $569K | ﹤0.01% |
5,612
-101
| -2% | -$10.5K |
|
1950
Fidelity MSCI Consumer Staples Index ETF
FSTA
$1.42B
| $568K | ﹤0.01% |
+13,127
| New | +$592K |
|
Similar funds
SCP
Thrivent Financial for Lutherans's Q2 2022 Portfolio in Review
As of Q2 2022, Thrivent Financial for Lutherans held 2,591 positions worth $37.5B, down 27% from $51.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Thrivent Financial for Lutherans withdrew a net $5.63B in Q2 2022, closing 185 positions and reducing 945 holdings. Its most notable exit was Vident US Equity Strategy ETF, an estimated $429M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Thrivent Financial for Lutherans opened a new position in Janus International worth $27.3M.
- Thrivent Financial for Lutherans's largest Q2 2022 buy was Janus International: 3,021,252 shares worth $27.3M.
- Thrivent Financial for Lutherans added most to Labcorp in Q2 2022, an estimated $217M increase.
- Thrivent Financial for Lutherans's biggest Q2 2022 reduction was iShares Core S&P US Value ETF, cutting an estimated $395M.
- Thrivent Financial for Lutherans fully exited Vident US Equity Strategy ETF in Q2 2022, selling an estimated $429M.
- Thrivent Financial for Lutherans's ten largest holdings make up 14% of its $37.5B portfolio in Q2 2022.
- Thrivent Financial for Lutherans opened 98 new positions and closed 185 in Q2 2022.
- Thrivent Financial for Lutherans's portfolio value fell 27% quarter-over-quarter to $37.5B.
Based on Thrivent Financial for Lutherans's 13F filing for Q2 2022, filed 16 Aug 2022.